Immediate Impact
1 from Science/Nature 56 standout
Citing Papers
Covalent targeted radioligands potentiate radionuclide therapy
2024 StandoutNature
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
2024 Standout
Works of Giordano Savelli being referenced
Yttrium-90 DOTATOC therapy in GEP-NET and other SST2 expressing tumors: a selected review
2010
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Giordano Savelli | 435 | 380 | 361 | 62 | 1.1k | |
| H. Bihl | 336 | 396 | 530 | 58 | 1.2k | |
| Matteo Salgarello | 397 | 260 | 261 | 65 | 975 | |
| Murat Fani Bozkurt | 421 | 468 | 230 | 53 | 952 | |
| Joseph Bovi | 143 | 380 | 324 | 63 | 1.1k | |
| Steven R. Isaacson | 318 | 400 | 153 | 45 | 1.4k | |
| Christof Rottenburger | 344 | 363 | 212 | 36 | 891 | |
| Giovanna Pepe | 358 | 406 | 299 | 33 | 864 | |
| Shaunak Navalkissoor | 552 | 566 | 177 | 69 | 914 | |
| Cumali Aktolun | 249 | 170 | 435 | 39 | 924 | |
| H M ABDEL-DAYEM | 193 | 192 | 458 | 70 | 1.0k |
All Works
Login with ORCID to disown or claim papers
Loading papers...